Quadrant Capital Group LLC Catabasis Pharmaceuticals, Inc. Transaction History
Quadrant Capital Group LLC
- $2.65 Billion
- Q1 2025
About Catabasis Pharmaceuticals, Inc.
- Ticker CATB
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,948,800
- Market Cap $657M